Slow-flow phenomenon after elective percutaneous coronary intervention of computed tomography-detected vulnerable

Rafał Wolny1, Artur Dębski1, Mariusz Kruk1

  • 1Institute of Cardiology, Warsaw, Poland.

Insights

The no-reflow phenomenon, a serious complication of percutaneous coronary interventions (PCI), can lead to poor outcomes. This case report details a patient experiencing slow-flow during elective PCI of a vulnerable coronary artery lesion.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • No-reflow or slow-flow phenomenon is a significant complication of percutaneous coronary interventions (PCI).
  • This phenomenon is an independent predictor of adverse cardiac events, including myocardial infarction and mortality.
  • Assessing lesion vulnerability prior to PCI is crucial for risk stratification.

Purpose of the Study:

  • To report a case of elective PCI complicated by the no-reflow phenomenon.
  • To highlight the role of coronary computed tomography angiography in identifying vulnerable lesions.
  • To discuss the management and implications of slow-flow during PCI.

Main Methods:

  • Coronary computed tomography angiography (CCTA) was used to assess lesion vulnerability.
  • An elective percutaneous coronary intervention (PCI) was performed on a native coronary artery.
  • The occurrence of the slow-flow phenomenon was documented during the procedure.

Main Results:

  • A vulnerable coronary artery lesion was identified using CCTA.
  • The patient developed a slow-flow phenomenon during the elective PCI.
  • This complication occurred despite the procedure being elective.

Conclusions:

  • The no-reflow/slow-flow phenomenon remains a critical complication in PCI, even in elective cases.
  • Pre-procedural assessment of lesion vulnerability, such as with CCTA, may aid in anticipating potential complications.
  • Further research is warranted to optimize strategies for preventing and managing slow-flow during PCI.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
437
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
813
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
503